• Latest Posts

New platform cuts time engineering and selecting genome editors

In Depth 27 Jun 2023

The promise of immunotherapy for autoimmune diseases

UCB myasthenia gravis drug given FDA approval 

Astraveus exits stealth to advance cell and gene therapy platform

Actimed Therapeutics raises £5M to advance lead program for cancer cachexia

ADVERTISEMENT

Laying the foundation for the future of personalized treatment?

Five animal health companies you should know about

AbbVie takes step forward in Europe with migraine drug

Six biotech companies in South Korea you should know about

New disease characteristic seen as NMD Pharma reports Charcot-Marie-Tooth results

ADVERTISEMENT